Hot
Human Integrin alpha V beta 1 (ITGAV&ITGB1) Heterodimer Protein, Tag Free&Tag FreeCat. No. IT1-H5213
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| IDL-2965 | IDL-2965 | Phase 2 Clinical | Indalo Therapeutics Inc | Idiopathic Pulmonary Fibrosis; Metabolic Dysfunction-Associated Steatotic Liver Disease | Details |
| Bexotegrast | PLN-74809 | Phase 2 Clinical | Pliant Therapeutics Inc | Cholangitis, Sclerosing; Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis; Respiratory Distress Syndrome, Adult | Details |
| PLN-1474 | PLN-1474 | Phase 1 Clinical | Pliant Therapeutics Inc | Liver Cirrhosis; Metabolic Dysfunction-Associated Steatotic Liver Disease | Details |
| PLN-101095 | PLN-101095 | Phase 1 Clinical | Pliant Therapeutics Inc | Solid tumours | Details |
| Cu-64-LLP2A | Cu-64-LLP2A; 64Cu-LLP2A | Phase 1 Clinical | University Of Pittsburgh | Anemia, Sickle Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Multiple Myeloma; Waldenstrom Macroglobulinemia | Details |
